Department Of Pulmonology 1

1. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
2. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
3. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
4. Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
5. Eosinophilic Inflammation in COPD: Mechanisms, Diagnostic Markers, Clinical Features and Therapy Guidance
6. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
7. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
8. The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
9. Unmet needs in hereditary angioedema: an international survey of physicians
10. One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
11. Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease
12. Severe genotype, pancreatic insufficiency and low dose of pancreatic enzymes associate with abnormal serum sterol profile in cystic fibrosis
13. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
14. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
15. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
16. Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights
17. Recombinant IgE-Reactive Functional Can f 5 Devoid of Cross-Reactive Carbohydrate Determinants
18. Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study
19. Chronic inducible urticaria – having more than one is common and clinically relevant
20. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
21. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
22. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
23. Obstructive sleep apnea in combination with bronchial asthma and chronic obstructive pulmonary disease
24. Obstructive sleep apnea in combination with bronchial asthma and chronic obstructive pulmonary disease
25. Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)
26. Predictive value of a severity-of-illness score for toxic epidermal necrolysis (SCORTEN) factors for in-hospital mortality in Stevens–Johnson syndrome/toxic epidermal necrolysis
27. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
28. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
29. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
30. Preventive ultrasound diagnosis of deep vein thrombosis of the lower extremities in patients with COVID-19
31. Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
32. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
33. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
34. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
35. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
36. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
37. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
38. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
39. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
40. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
41. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
42. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
43. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data
44. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
45. Parameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria—Chronic Urticaria Registry Results
46. Recombinant Hypoallergenic Cat Allergy Vaccines
47. Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
48. The cytotoxic, antioxidant, and anticholinesterase activity of steviol and isosteviol analogues, together with structure-activity relationships and molecular docking studies
49. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
50. Waiting List Monitoring for Kidney Transplant Patients With Terminal Chronic Renal Failure in Kazakhstan
1